Timing and Dose of Statin Therapy Define Its Impact on Inflammatory and Endothelial Responses During Myocardial Infarction
- 1 May 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (5) , 1240-1246
Abstract
Objective—: Clinical trials of statins during myocardial infarction (MI) have differed in their therapeutic regimes and generated conflicting results. This study evaluated the role of the timing and potency of statin therapy on its potential mechanisms of benefit during MI. Methods and Results—: ST-elevation MI patients (n=125) were allocated into 5 groups: no statin; 20, 40, or 80 mg/day simvastatin starting at admission; or 80 mg/day simvastatin 48 hours after admission. After 7 days, all patients switched their treatment to 20 mg/day simvastatin for an additional 3 weeks and then underwent flow-mediated dilation in the brachial artery. As of the second day, C-reactive protein (CRP) differed between non–statin users (12.0±4.1 mg/L) and patients treated with 20 (8.5±4.0 mg/L), 40 (3.8±2.5 mg/L), and 80 mg/day (1.4±1.5 mg/L), and the daily differences remained significant until the seventh day ( P P P P =0.001). Conclusion—: This study demonstrates that the timing and potency of statin treatment during MI are key elements for their main mechanisms of benefit. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00906451.Keywords
This publication has 18 references indexed in Scilit:
- Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary interventionCoronary Artery Disease, 2009
- Statins in Acute Coronary SyndromesJACC, 2009
- Patients using statin treatment within 24 h after admission for ST-elevation acute coronary syndromes had lower mortality than non-users: a report from the first Euro Heart Survey on acute coronary syndromesEuropean Heart Journal, 2006
- Detection of electronegative low density lipoprotein (LDL−) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassaysClinical Biochemistry, 2006
- Intensity of Lipid Lowering With Statins and Brachial Artery Vascular Endothelium Reactivity After Acute Coronary Syndromes (from the BRAVER Trial)The American Journal of Cardiology, 2005
- Brachial Artery Vasodilator Function and Systemic Inflammation in the Framingham Offspring StudyCirculation, 2004
- Prognostic Value of Systemic Endothelial Dysfunction in Patients With Acute Coronary SyndromesCirculation, 2004
- Inflammatory Cytokines and Postmyocardial Infarction RemodelingCirculation Research, 2004
- Statin Therapy in Acute Coronary SyndromesArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Reduced Coronary Vasodilator Function in Infarcted and Normal Myocardium after Myocardial InfarctionNew England Journal of Medicine, 1994